bioRxivCancer BiologyPreprint
Single cell derived organoids capture the self-renewing subpopulations of metastatic ovarian cancer
T. Velletri, C. E. Villa, M. Lupia, P. Lo riso, R. Luongo, A. Lopez Tobon, M. De Simone, R. J. P. Bonnal, S. Minucci, S. Piccolo, N. Colombo, M. Pagani, U. Cavallaro, G. Testa
Abstract
High Grade Serous Ovarian cancer (HGSOC) is a major unmet need in oncology, due to its precocious dissemination and the lack of meaningful human models for the investigation of disease pathogenesis in a patient-specific manner. To overcome this roadblock, we present a new method to isolate and grow single cells directly from patients ascites, establishing the conditions for propagating them as single-cell derived ovarian cancer organoids (scOCOs). By single cell RNA sequencing (scRNAseq) we define the cellular composition of metastatic ascites and trace its propagation in 2D and 3D culture paradigms, finding that scOCOs retain and amplify key subpopulations from the original patients samples and recapitulate features of the original metastasis that do not emerge from classical 2D culture, including retention of individual patients specificities. By enabling the enrichment of uniquely informative cell subpopulations from HGSOC metastasis and the clonal interrogation of their diversity at the functional and molecular level, this method transforms the prospects of precision oncology for ovarian cancer.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell transcriptomics of heterogeneous patient-derived organoids reveals novel therapeutic targets in high-grade serous ovarian cancer
Bisiayo Fashemi, Yukihide Ota, … Dineo Khabele·bioRxiv·Jun 9, 2026
- A platform for efficient establishment, expansion and drug response profiling of high-grade serous ovarian cancer organoids
W. Senkowski, L. Gall-Mas, … K. Wennerberg·bioRxiv·Apr 21, 2022
- Cancer stem cell transcriptomic signatures reveal patient-to-patient heterogeneity emphasizing the need for patient-specific ovarian cancer targets
Matthew S. Jung, Lindsey J. Davis, … Rachel S. Perkins·bioRxiv·Oct 2, 2026
- Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma
L. Geistlinger, S. Oh, … L. Waldron·bioRxiv·Jun 12, 2020
- A Rare Multipotent Peg-like Epithelial Cell is a Candidate Cell-of-Origin for High-Grade Serous Ovarian Cancer
Megan L. Ritting, Wenmei Yang, … Nagarajan Kannan·bioRxiv·Sep 23, 2025
- Both Fallopian Tube and Ovarian Surface Epithelium Can Act as Cell-of-Origin for High Grade Serous Ovarian Carcinoma
B. G. Neel, S. Zhang, … D. A. Levine·bioRxiv·Nov 29, 2018